Effectiveness and Safety of the Allurion Swallowable Intragastric Balloon for Short-term Weight Loss: A Systematic Review and Meta-analysis.
Obes Surg
; 34(10): 3735-3747, 2024 Oct.
Article
em En
| MEDLINE
| ID: mdl-39174862
ABSTRACT
BACKGROUND:
Obesity poses a severe health problem worldwide, with an estimated impact on 17.5% of the adult population by 2035. Among the endoscopic applications for treating this comorbidity, intragastric balloons are the most widely used. The new liquid-filled swallowable balloon meets the requirements of major guidelines and allows significant weight loss with few adverse events. This systematic review and meta-analysis aims to demonstrate the efficacy and safety profile of this new device for weight loss.METHODS:
We conducted a search from 2016 to 2024 to assess the efficacy of the swallowable intragastric balloon for weight loss, including improvements in metabolic profiles and anthropometric measurements. Additionally, we evaluated potential adverse events related to the device to demonstrate its safety.RESULTS:
Eleven observational studies totalling 2107 patients were included, showing a reduction of 4.75 in BMI (95% CI -5.02; -4.47), a mean total weight loss of 12.47% (95% CI -13.77; -11.17), a mean excess weight loss of 48.04% (95% CI -50.61; -45.48), and a rate of serious adverse events of 0.90%. An improvement in the metabolic profile was observed for three parameters HDL, triglycerides, and glycaemia.CONCLUSION:
The swallowable liquid-filled intragastric balloon is safe and effective for managing weight loss within a four-month follow-up period.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Obesidade Mórbida
/
Redução de Peso
/
Balão Gástrico
Limite:
Adult
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Obes Surg
Assunto da revista:
METABOLISMO
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Brasil
País de publicação:
Estados Unidos